Related Experiment Video
Updated: Sep 17, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
The NLRP3 Mediates Masticatory Muscle Atrophy by Pyroptosis and Mitophagy
1College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, China.
Abstract:
Masticatory muscle atrophy is relatively common and affects occlusal function, facial appearance, and even quality of life. The molecular mechanisms underlying changes in the masticatory muscles remain largely unknown. The Nod-like receptor protein 3 (NLRP3) inflammasome has been extensively reported to be associated with various myopathies; however, little is known about its role in masticatory muscle atrophy. Here, we investigated the function and underlying mechanisms of NLRP3 inflammasome activation in muscle atrophy models both in vitro and in vivo. First, significant atrophy of the masticatory muscles was observed after excessive orthodontic traction in rats, with NLRP3 inflammasome activation leading to increased myocyte pyroptosis. Further observations in the atrophied masticatory muscles revealed a significant reduction in mitochondrial number and overactivation of mitophagy. Conversely, inhibiting NLRP3 suppressed the expression of pyroptosis-related proteins and alleviated muscle atrophy. Moreover, blocking the activation of the NLRP3 inflammasome considerably alleviated mitochondrial dysfunction in the atrophied masticatory muscles and reduced excessive mitophagy, thereby maintaining intracellular homeostasis and preserving muscle mass. In addition, the results of the in vitro experiments confirmed that knocking down NLRP3 significantly alleviated NLRP3 agonist-induced pyroptosis and atrophy in the myotubes, improved mitochondrial damage, maintained mitochondrial membrane potential (Δψm), and decreased reactive oxygen species production. In summary, this study demonstrates that the NLRP3 inflammasome induces pyroptosis, mitochondrial dysfunction, and mitophagy, thereby becoming an important regulatory factor for masticatory muscle atrophy. Our research provides new insights into the mechanism of masticatory muscle atrophy.
Insights
The Nod-like receptor protein 3 (NLRP3) inflammasome drives masticatory muscle atrophy by causing cell death and mitochondrial damage. Inhibiting NLRP3 protects against muscle loss and dysfunction.
Area of Science:
- Biomedical Science
- Molecular Biology
- Muscle Physiology
Background:
- Masticatory muscle atrophy impacts occlusal function, facial aesthetics, and quality of life.
- The molecular underpinnings of masticatory muscle atrophy are not well understood.
- The Nod-like receptor protein 3 (NLRP3) inflammasome is implicated in various myopathies, but its role in masticatory muscle atrophy is unclear.
Purpose of the Study:
- To investigate the role and mechanisms of NLRP3 inflammasome activation in masticatory muscle atrophy.
- To explore NLRP3 inflammasome's impact on myocyte pyroptosis, mitochondrial function, and mitophagy in muscle atrophy models.
Main Methods:
- Utilized in vivo rat models with excessive orthodontic traction to induce masticatory muscle atrophy.
- Conducted in vitro experiments on myotubes to assess NLRP3 inflammasome activation effects.
- Employed molecular and cellular assays to evaluate pyroptosis, mitochondrial integrity, and mitophagy.
Main Results:
- Excessive orthodontic traction in rats induced masticatory muscle atrophy with NLRP3 inflammasome activation and increased myocyte pyroptosis.
- Atrophied muscles showed reduced mitochondrial numbers, overactivated mitophagy, and impaired mitochondrial function.
- Inhibition of NLRP3 suppressed pyroptosis, alleviated muscle atrophy, improved mitochondrial dysfunction, and reduced excessive mitophagy.
- In vitro studies confirmed that NLRP3 knockdown mitigated pyroptosis, atrophy, mitochondrial damage, and reactive oxygen species production.
Conclusions:
- NLRP3 inflammasome activation is a key driver of masticatory muscle atrophy.
- NLRP3 induces pyroptosis, mitochondrial dysfunction, and mitophagy, contributing to muscle mass loss.
- Targeting the NLRP3 inflammasome presents a potential therapeutic strategy for masticatory muscle atrophy.

